Key statistics
As of last trade, Hemogenyx Pharmaceuticals PLC (5HU:STU) traded at 0.0135, 35.00% above the 52 week low of 0.01 set on Nov 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.0135 |
---|---|
High | 0.0135 |
Low | 0.0135 |
Bid | 0.015 |
Offer | 0.0235 |
Previous close | 0.015 |
Average volume | 0.00 |
---|---|
Shares outstanding | 1.40bn |
Free float | 1.26bn |
P/E (TTM) | -- |
Market cap | 21.38m GBP |
EPS (TTM) | -0.0042 GBP |
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Announcements
- IRB Approval for Phase I Clinical Trial
- Institutional Investment
- Schedule for Phase I Clinical Trial Opening
- Strategic Investment from Prevail Partners, LLC
- Half-year Report
- FLT3 Assay Ready for Phase I Trials at MD Anderson
- CDX Development Update
- Presentation at CBD S&T Conference
- Macrophage-Directed Therapies Summit Presentation
- Result of Annual General Meeting
More ▼